Concepedia

Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-Ay/Ta mice

Mitsuo Tanimoto, Tomohito Gohda, Shigeru Kaneko, Shinji Hagiwara, Maki Murakoshi, Tatsuya Aoki, Kaori Yamada, Takamichi Ito, Masakazu Matsumoto, Satoshi Horikoshi,

Metabolism · 2007 · 91 citations · 34 references

DOI

Concepts

References

34

Oxidative stress and apoptosis

Krishnaswamy Kannan, Sushil K. Jain · Pathophysiology · 2000 · 1.3K citations · Full text

, , +12

Aminoguanidine Prevents Diabetes-Induced Arterial Wall Protein Cross-Linking

M. Brownlee, Helen Vlassara, A. Kooney et al. · Science · 1986 · 1.1K citations

, , +15

Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE

Marie‐Paule Wautier, Olivier Chappey, Stefano Corda et al. · American Journal of Physiology-Endocrinology and Metabolism · 2001 · 1.1K citations

, , +17

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.

Kyoji Horie, Toshio Miyata, Kenji Maeda et al. · Journal of Clinical Investigation · 1997 · 431 citations · Full text

, , +17

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat

Thorsten P. Degenhardt, Nathan L. Alderson, David D. Arrington et al. · Kidney International · 2002 · 377 citations

, , +11